Oral iron for children with chronic kidney disease
Treatments studied
Part of Blood & lymphatic, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial studies whether taking iron by mouth can improve iron levels and anemia (low red blood cell counts) in children with chronic kidney disease. It may help reduce fatigue and support normal blood-making, by comparing different approaches for children who meet specific iron test results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 1 to 21 years old
- Have chronic kidney disease with a measured kidney function estimate (GFR) under 90
- At your last clinic visit, hemoglobin (Hb) was at least 9.0 but still below the age/sex cutoffs listed
- At the last tests, have iron levels that match the study’s low/normal range: transferrin saturation 20% or less and ferritin 100 ng/mL or less
- Not be on iron supplements or medicines that help red blood cell production (like erythropoietin) within the last 3 months
- Not be on hemodialysis, not have had a blood transfusion in the last 4 months, and not be expecting dialysis/transplant soon
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests ferric citrate, a medicine that helps control phosphate and iron balance, in children with chronic kidney disease. It may help slow problems related to kidney disease by improving lab measures like phosphate levels.
This trial studies IV ferric derisomaltose to treat iron deficiency anemia in children under 18. It is meant for children whose anemia is from a true iron problem and who either cannot tolerate or do not respond to iron taken by mouth, or have certain kidney-related causes.
This trial tests a type of IV iron called ferric carboxymaltose to treat children with iron deficiency anemia in the emergency department. It aims to find a safe and effective way to quickly raise hemoglobin levels.
This study compares two IV iron treatments—ferumoxytol and iron sucrose—to treat iron deficiency anemia in children with chronic kidney disease. It aims to see which option works better and is safe, and also to learn how each medicine behaves in the body.
This trial tests ferumoxytol, an intravenous iron medicine, to treat iron deficiency anemia in children who cannot take or did not respond well to iron by mouth. It aims to improve blood iron levels and anemia symptoms safely.
This trial tests whether a higher or lower dose of iron works better for people on peritoneal dialysis who have low iron levels. It aims to find the best way to treat iron deficiency in this group.
Hear when a new Chronic Kidney Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.